Safety and antitumor activity of dostarlimab in patients with advanced or recurrent DNA mismatch repair deficient/microsatellite instability-high (dMMR/MSI-H) or proficient/stable (MMRp/MSS) endometrial cancer: interim results from GARNET—a phase I, single-arm study

BackgroundDostarlimab is a humanized monoclonal antibody that binds with high affinity to PD-1, resulting in inhibition of binding to PD-L1 and PD-L2. We report interim data from patients with endometrial cancer (EC) participating in a phase I trial of single-agent dostarlimab.MethodsGARNET, an ongo...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal for immunotherapy of cancer Ročník 10; číslo 1; s. e003777
Hlavní autoři:	Oaknin, Ana, Gilbert, Lucy, Tinker, Anna V, Brown, Jubilee, Mathews, Cara, Press, Joshua, Sabatier, Renaud, O’Malley, David M, Samouelian, Vanessa, Boni, Valentina, Duska, Linda, Ghamande, Sharad, Ghatage, Prafull, Kristeleit, Rebecca, Leath III, Charles, Guo, Wei, Im, Ellie, Zildjian, Sybil, Han, Xinwei, Duan, Tao, Veneris, Jennifer, Pothuri, Bhavana
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England BMJ Publishing Group Ltd 01.01.2022 BMJ Publishing Group LTD BMJ Publishing Group
Edice:	Original research
Témata:	Antibodies, Monoclonal, Humanized - pharmacology Antibodies, Monoclonal, Humanized - therapeutic use Biomarkers Biomarkers, Tumor - metabolism Cancer Cell death clinical trials as topic Clinical/Translational Cancer Immunotherapy DNA Mismatch Repair - drug effects Endometrial cancer Endometrial Neoplasms - drug therapy Enrollments Female Humans Hypotheses Immunotherapy Laboratories Life Sciences Microsatellite Instability - drug effects Middle Aged Monoclonal antibodies Mutation Patients programmed cell death 1 receptor Proteins Response rates Targeted cancer therapy Tumors clinical trials as topic programmed cell death 1 receptor immunotherapy
ISSN:	2051-1426, 2051-1426
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!